UBS analyst Kevin Caliendo lowered the firm’s price target on Envista (NVST) to $18 from $21 and keeps a Neutral rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVST:
- Cautious Outlook on Envista Holdings Amid Uncertain Dental Demand and Geographic Challenges
- Envista Holdings’ Earnings Call: Balanced Growth Amid Challenges
- Envista price target lowered to $21 from $23 at Baird
- Balanced Outlook on Envista Holdings: Hold Rating Amid Stable Dental Market and Macroeconomic Caution
- Envista Holdings Reports Steady Q1 2025 Performance